Top

Published in:

01-11-2016 | Head and Neck

Dynamic contrast-enhanced MRI, diffusion-weighted MRI and ¹⁸F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation

Authors: Shu-Hang Ng, Chun-Ta Liao, Chien-Yu Lin, Sheng-Chieh Chan, Yu-Chun Lin, Tzu-Chen Yen, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Kang-Hsing Fan, Hung-Ming Wang, Lan-Yan Yang, Jiun-Jie Wang

Published in: European Radiology | Issue 11/2016

Abstract

Objectives

We prospectively investigated the roles of pretreatment dynamic contrast-enhanced MR imaging (DCE-MRI), diffusion-weighted MR imaging (DWI) and ¹⁸F-fluorodeoxyglucose-positron emission tomography (¹⁸F-FDG PET)/CT for predicting survival of oropharyngeal or hypopharyngeal squamous cell carcinoma (OHSCC) patients treated with chemoradiation.

Methods

Patients with histologically proven OHSCC and neck nodal metastases scheduled for chemoradiation were eligible. Clinical variables as well as DCE-MRI-, DWI- and ¹⁸F-FDG PET/CT-derived parameters of the primary tumours and metastatic neck nodes were analysed in relation to 3-year progression-free survival (PFS) and overall survival (OS) rates.

Results

Eighty-six patients were available for analysis. Multivariate analysis identified the efflux rate constant (K _ep)-tumour < 3.79 min⁻¹ (P = 0.001), relative volume of extracellular extravascular space (V _e)-node < 0.23 (P = 0.004) and SUV_max-tumour > 19.44 (P = 0.025) as independent risk factors for both PFS and OS. A scoring system based upon the sum of each of the three imaging parameters allowed stratification of our patients into three groups (patients with 0/1 factor, patients with 2 factors and patients with 3 factors, respectively) with distinct PFS (3-year rates = 72 %, 38 % and 0 %, P < 0.0001) and OS (3-year rates = 81 %, 46 % and 20 %, P < 0.0001).

Conclusions

K _ep-tumour, V _e-node and SUV_max-tumour were independent prognosticators for OHSCC treated with chemoradiation. Their combination helped survival stratification.

Key Points

• K _ep -tumour, V _e -node and SUV _max -tumour are independent predictors of survival rates.

• The combination of these three prognosticators may help stratification of survival.

• MRI and FDG-PET/CT play complementary roles in prognostication of head and neck cancer.

Urba SG, Moon J, Giri PG et al (2005) Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 23:88–95CrossRefPubMed

Wang HM, Hsu CL, Hsieh CH et al (2014) Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Biomed J 37:133–140PubMed

Ohnishi K, Shioyama Y, Hatakenaka M et al (2011) Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma. J Radiat Res 52:522–530CrossRefPubMed

Chawla S, Kim S, Dougherty L et al (2013) Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol 200:35–43CrossRefPubMedPubMedCentral

Ng SH, Lin CY, Chan SC et al (2013) Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One 8, e72230CrossRefPubMedPubMedCentral

King AD, Mo FK, Yu KH et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213–2220CrossRefPubMed

Hatakenaka M, Nakamura K, Yabuuchi H et al (2011) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 81:339–345CrossRefPubMed

Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986–994CrossRefPubMedPubMedCentral

Kim S, Loevner LA, Quon H et al (2010) Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 31:262–268CrossRefPubMed

10.

Nakajo M, Nakajo M, Kajiya Y et al (2012) FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Clin Nucl Med 37:475–480CrossRefPubMed

11.

Hatakenaka M, Nakamura K, Yabuuchi H et al (2014) Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy. Jpn J Radiol 32:80–89CrossRefPubMed

12.

Lambrecht M, Van Calster B, Vandecaveye V et al (2014) Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 110:429–434CrossRefPubMed

13.

Jansen JF, Schoder H, Lee NY et al (2012) Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. Int J Radiat Oncol Biol Phys 82:299–307CrossRefPubMed

14.

Chawla S, Kim S, Loevner LA et al (2011) Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 32:778–784CrossRefPubMed

15.

Shukla-Dave A, Lee NY, Jansen JF et al (2012) Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 82:1837–1844CrossRefPubMed

16.

Ng SH, Lin CY, Chan SC et al (2014) Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 9, e115933CrossRefPubMedPubMedCentral

17.

Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59:1295–1300CrossRefPubMed

18.

Torizuka T, Tanizaki Y, Kanno T et al (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192:W156–W160CrossRefPubMed

19.

Seol YM, Kwon BR, Song MK et al (2010) Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncol 49:201–208CrossRefPubMed

20.

Vernon MR, Maheshwari M, Schultz CJ et al (2008) Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 70:678–684CrossRefPubMed

21.

Demirci U, Coskun U, Akdemir UO et al (2011) The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer. Asian Pac J Cancer Prev 12:1817–1820PubMed

22.

Schwartz DL, Rajendran J, Yueh B et al (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130:1361–1367CrossRefPubMed

23.

Liao CT, Chang JT, Wang HM et al (2009) Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging 36:1783–1793CrossRefPubMed

24.

Kubicek GJ, Champ C, Fogh S et al (2010) FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2:19CrossRefPubMedPubMedCentral

25.

Tang C, Murphy JD, Khong B et al (2012) Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys 83:1514–1520CrossRefPubMedPubMedCentral

26.

Kim SY, Roh JL, Kim MR et al (2007) Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48:752–757CrossRefPubMed

27.

Lim R, Eaton A, Lee NY et al (2012) 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. J Nucl Med 53:1506–1513CrossRefPubMed

28.

Chung MK, Jeong HS, Park SG et al (2009) Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 15:5861–5868CrossRefPubMed

29.

Cheng NM, Chang JT, Huang CG et al (2012) Prognostic value of pretreatment (18)F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-012-2186-9

30.

Liao CT, Chang JT, Wang HM et al (2009) Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 73:764–771CrossRefPubMed

31.

Wang HM, Wang CS, Chen JS, Chen IH, Liao CT, Chang TC (2002) Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 94:2989–2995CrossRefPubMed

32.

Noij DP, Pouwels PJ, Ljumanovic R et al (2015) Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma. Eur J Radiol 84:108–116CrossRefPubMed

33.

Schabel MC, Parker DL (2008) Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 53:2345–2373CrossRefPubMedPubMedCentral

34.

Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed

35.

Lin YC, Chan TH, Chi CY et al (2012) Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization. Magn Reson Med. doi:10.1002/mrm.24144

36.

Chan SC, Hsu CL, Yen TC, Ng SH, Liao CT, Wang HM (2013) The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma. Oral Oncol 49:71–78CrossRefPubMed

37.

Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M (2002) FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86:512–516CrossRefPubMedPubMedCentral

38.

Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17:357–367CrossRefPubMed

39.

Tofts PS (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7:91–101CrossRefPubMed

40.

Zahra MA, Tan LT, Priest AN et al (2009) Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74:766–773CrossRefPubMed

41.

Jansen JF, Schoder H, Lee NY et al (2010) Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 77:1403–1410CrossRefPubMed

42.

Coenegrachts K, Bols A, Haspeslagh M, Rigauts H (2012) Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis. Eur J Radiol 81:3870–3876CrossRefPubMed

43.

Koh TS, Ng QS, Thng CH, Kwek JW, Kozarski R, Goh V (2013) Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome. Radiology 267:145–154CrossRefPubMed

44.

Sumi M, Nakamura T (2014) Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types. Eur Radiol 24:223–231CrossRefPubMed

45.

Zhang SX, Jia QJ, Zhang ZP et al (2014) Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site. Eur Radiol 24:1998–2004CrossRefPubMedPubMedCentral

46.

Higgins KA, Hoang JK, Roach MC et al (2012) Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys 82:548–553CrossRefPubMed

47.

Purohit BS, Ailianou A, Dulguerov N, Becker CD, Ratib O, Becker M (2014) FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging 5:585–602CrossRefPubMedPubMedCentral

Title: Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation
Authors: Shu-Hang Ng
Chun-Ta Liao
Chien-Yu Lin
Sheng-Chieh Chan
Yu-Chun Lin
Tzu-Chen Yen
Joseph Tung-Chieh Chang
Sheung-Fat Ko
Kang-Hsing Fan
Hung-Ming Wang
Lan-Yan Yang
Jiun-Jie Wang
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 11/2016
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4276-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dynamic contrast-enhanced MRI, diffusion-weighted MRI and ¹⁸F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 11/2016

Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance

Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon emission computed tomography

Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension

Gouty arthritis: the diagnostic and therapeutic impact of dual-energy CT

18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction

Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution